L’ASAQ, une avancée dans la lutte contre le paludisme [ASAQ, an advance in the battle against malaria].
Abstract
This editorial (in French) presents ASAQ, a fixed-dose combination of artesunate and amodiaquine launched in March 2007 by the Drugs for Neglected Diseases initiative (DNDi) and sanofi-aventis. The combination is intended for treating uncomplicated Plasmodium falciparum malaria in malaria-endemic countries in Africa.
Citation
Kiechel, J.R.; Pécoul, B. L’ASAQ, une avancée dans la lutte contre le paludisme [ASAQ, an advance in the battle against malaria]. Medecine Tropicale (2007) 67 (2) 109-110.
Links
- kiechel_pecoul_med_trop_2007_p109.pdf
- [109-110-_editorial-pecoul_109-110-editorial-pecoul.pdf](http://www.revuemedecinetropicale.com/109-110-editorial-pecoul_109-110-editorial-_pecoul.pdf)